Taysha Gene Therapies Inc
Taysha Gene Therapies Inc (TSHA) Option Chain
As of September 23, 2026, Taysha Gene Therapies Inc is trading at $4.91, a -4.85% change from the previous close. The nearest expiration is Oct 16, 2026. Implied volatility is 89.8%. IV Rank is 10%.
Read more
Tracking the TSHA option chain helps you see every strike and expiry on Taysha Gene Therapies Inc in one view, so you can quickly identify the contracts that fit your thesis and your risk. Taysha Gene Therapies Inc's option chain lays out bids, asks, volume, open interest, and Greeks across calls and puts, giving you the full map of TSHA options activity at a glance. Use our scanner to monitor the TSHA option chain in real time and filter for the TSHA options trades that actually meet your criteria.
An option chain is the complete listing of all available option contracts on an underlying, organized by expiration date and strike price. For TSHA stock options, the chain shows side-by-side call and put data, making it easy to compare premiums, assess liquidity, and spot pricing dislocations. Reading the TSHA option chain effectively means looking beyond the last price — implied volatility by strike, volume-to-open-interest ratios, and bid-ask spreads all tell you where TSHA stock options are being actively traded and where they are not.
Taysha Gene Therapies, Inc., a gene therapy company, focuses on developing and commercializing adeno-associated virus-based gene therapies for the treatment of monogenic diseases of the central nervous system. It primarily develops TSHA-120 for the treatment of giant axonal neuropathy; TSHA-102 for the treatment of Rett syndrome; TSHA-121 for the treatment of CLN1 disease; TSHA-118 for the treatment of CLN1 disease; TSHA-105 foe the treatment of for SLC13A5 Deficiency; and TSHA-101 for the treatment of GM2 gangliosidosis. Taysha Gene Therapies, Inc. has a strategic partnership with The University of Texas Southwestern Medical Center to develop and commercialize transformative gene therapy treatments.
The company was incorporated in 2019 and is based in Dallas, Texas.
Credit spreads, long calls, iron condors, calendar trades — every strategy starts with the same raw material: a clean, complete option chain. Our scanner pulls Taysha Gene Therapies Inc's full chain across every expiry, highlights the most liquid strikes, and lets you screen TSHA options by the metrics that matter, from IV skew to volume surges. Stop scrolling through endless rows of TSHA stock options — let the full option chain come to you, pre-filtered and ready to trade.
Stock Statistics
- IndustryBiotechnology
- SectorHealthcare
- IV percentile59.92% Neutral
- Market cap (M$)1,600
- 52 weeks high-32.74%
- 52 weeks low68.73%
- Analyst recommendationStrong Buy
1.08 - Target price$13.00
164.77% above the current stock price - Dividend—
- Payout ratio—
- Earnings date2026-11-03
- P/E—
- Future P/E—
- EPS (ttm)-0.43
- EPS growth next 5 years10.86%
As of September 23, 2026
| CALLs | PUTs | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Prob. OTM % | Open Interest | Volume | Extrinsic Value | Intrinsic Value | Bid | Ask | Strike | Moneyness % | Bid | Ask | Intrinsic Value | Extrinsic Value | Volume | Open Interest | Prob. OTM % |
| 2.08 | 0 | 0 | 0.29 | 1.91 | 1.70 | 2.70 | 3.00 | -41.86 | — | 0.05 | 0.00 | 0.05 | 0 | 0 | 97.92 |
| 18.52 | 19 | 0 | 0.34 | 0.91 | 0.75 | 1.75 | 4.00 | -22.48 | — | 0.25 | 0.00 | 0.25 | 0 | 10 | 81.48 |
| 49.62 | 556 | 0 | 0.65 | 0.00 | 0.15 | 1.15 | 5.00 | -3.10 | 0.10 | 0.55 | 0.09 | 0.24 | 1 | 148 | 50.38 |
| 76.26 | 683 | 11 | 0.50 | 0.00 | — | 0.50 | 6.00 | +16.28 | 0.65 | 1.65 | 1.09 | 0.06 | 0 | 143 | 23.74 |
| 90.77 | 1,074 | 0 | 0.20 | 0.00 | — | 0.20 | 7.00 | +35.66 | 1.50 | 2.50 | 2.09 | -0.09 | 0 | 0 | 9.23 |
As of September 23, 2026
Scan the full option chain in one place
Browse the full TSHA option chain across every strike and expiration, filter by IV, volume, and open interest, and evaluate your trade without switching tools.
Start your 14-day free trial→